Linking anti-MUC1 and anti-CD16 VHH fragments recruits natural killer cells to tumor sites, resolving manufacturing complexity and short half-life issues.
Deformable organic overcoating protects non-deformable cores during tablet compression to maintain prolonged release profiles.
A cleavable peptide links two spectrally distinct radionuclides to enable simultaneous detection and imaging of enzyme activity using Single Photon Emission Computed Tomography.
Amino acid-based polymers replace unstable PGLA matrices to maintain bacteriophage integrity against enzymatic degradation and immune clearance.
Segmenting viral proteins into discrete epitopes avoids adverse side effects while maintaining reliability for immunocompromised individuals.
Biodegradable amphiphilic polymer vesicles utilize disulfide crosslinking to achieve stable in vivo circulation and targeted drug delivery.
Sub-micron particle sizing and controlled dissolution in a unit dosage form reduce food-induced variability in systemic exposure.
Segmented ADAMTS13 with stabilizers achieves 80% bioavailability, resolving low absorption and stability trade-offs in subcutaneous delivery.
A dual-scale porous silica vaccine uses microparticle scaffolds to recruit dendritic cells and enhance nanoparticle uptake.
Composite particles with vinyl formal, alcohol, and acetate units resolve durability versus precision trade-offs in targeted drug delivery.
Adsorbent pharmaceutical composition mitigates pulmonary edema and cytokine storm severity while preserving immune function.
Polymeric nanoparticles protect enzymes from protease degradation, extending half-life and enhancing blood-brain barrier delivery.
A magnetically actuated system guides cell-laden scaffolds to cartilage defects for precise regeneration.
A pharmaceutical composition combining colostrum with vitamin D3 neutralizes bacterial lipopolysaccharides in the gastrointestinal tract.
Bromelain proteolytic extract dissolves Dupuytren's cords via enzymatic hydrolysis, sparing healthy tissue and reducing surgical complications.
Surface-modified nanoparticles deposit on active pharmaceutical ingredient particles to enhance flowability and dispersibility.
Encapsulating bioactive proteins in a glassy matrix preserves biological activity despite harsh manufacturing and storage conditions.
One lyophilization cycle controls pH between 5 and 7, resolving complexity while ensuring injectability.
Composite core/shell nanoparticles extend blood half-life and enable targeted delivery while reducing toxicity compared to iodinated agents.
Anti-inflammatory protein functionalization on hyaluronic acid coated chitosan nanoparticles suppresses immune activation and extends circulation time.
Multipartite VI-SMR peptides combine secretion modulation with viral attachment inhibition to treat SARS-CoV-2 infections.
Silk fibroin solution and spun mat compositions strengthen skin against mechanical stresses while maintaining biocompatibility.
A conductive thermal block with wells secures containers for uniform heating, eliminating non-uniform drying patterns that extend batch cycle times.
Dissolving carotenoids in dichloromethane and precipitating them using a high gravity rotating packed bed creates nano-dispersed microcapsules.
A multi-compartment device stabilizes blood components by reducing water activity below 0.9 using a semi-permeable membrane.
Inhaled argon gas maintains cardiac output and perfusion pressure, preventing cardiogenic shock and organ damage during cardiovascular surgery.
High molecular weight stachyose stabilizes polymerases against hydration and storage degradation while preventing formulation inhibition.
Sodium bicarbonate and carbonate neutralize odors while botanical extracts inhibit bacteria, avoiding aluminum salt health risks.
A flexible hollow cavity device confines enzyme solution to a local tissue area for targeted enzymatic treatment.
Acid mixing of date palm seed powder yields nanoparticles that inhibit bacterial growth without toxic additives.
Inhalation spray atomizes semaglutide into fine particles to bypass first-pass metabolism and achieve high bioavailability.
Alkylglycosides replace polysorbates to prevent fatty acid byproducts that cause turbidity and protein aggregation.
Amphiphilic block copolymer micelles encapsulate hydrophobic taxanes within a modified core to enhance drug compatibility and loading efficiency.
C-terminal fragment C-CPE modulates claudin-4 to increase tight junction permeability, enabling safe mucosal peptide absorption without tissue damage.
Nano-milling creates stable phenolic particles in edible lipids, resolving formulation complexity while maintaining bioavailability over months.
Modular bispecific antibodies assembled via DOCK-AND-LOCK overcome low yields and poor stability from traditional quadroma fusion methods.
Lactobacillus paracasei DG down-regulates iNOS expression and pro-inflammatory cytokines to control persistent inflammation in diverticular disease.
Selective RXR agonists resolve the contradiction between effective immune modulation and pro-inflammatory side effects by targeting specific receptor pathways.
A growth factors-enriched dry powder relieves inflammation through freeze-dried purification.